6 Results for "

unphosphorylated

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "unphosphorylated" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-112821
CAS No.: 385425-03-6
Purity:  98.22%
Target:  

YAP

Research Areas:  

Inflammation/Immunology

IBS008738 is a potent TAZ activator. IBS008738 stabilizes TAZ, increases the unphosphorylated TAZ level, enhances the association of MyoD with the myogenin promoter, upregulates MyoD-dependent gene transcription, and competes with myostatin in C2C12 cells. IBS008738 enhances myogenesis in C2C12 cells and facilitates muscle repair in a muscle injury model .
loading...
    loading...
Cat. No.: HY-123956
CAS No.: 2222354-57-4
Target:  

IRAK

Research Areas:  

Inflammation/Immunology

HG-12-6 is a type II inhibitor of IRAK4. HG-12-6 shows preferential binding to unphosphorylated inactive IRAK4 with an IC50 of 165 nM. HG-12-6 can modulate IRAK4 activity in autoimmunity and inflammation .
loading...
    loading...
Cat. No.: HY-111947
CAS No.: 1628574-81-1
Target:  

c-Fms

Research Areas:  

Inflammation/Immunology

c-Fms-IN-6 is a potent inhibitor of c-FMS, with an IC50 of ≤10 nM for unphosphorylated c-FMS, also weakly inhibits unphosphorylated c-KIT and PDGFR (IC50, > 1 μM). Used in the research of autoimmune diseases .
loading...
    loading...
Cat. No.: HY-128680
CAS No.: 1628574-50-4
Target:  

c-Fms

Research Areas:  

Cancer

c-Fms-IN-9 is a c-FMS inhibitor extracted from patent WO2014145023A1, Compound Example 7. c-Fms-IN-9 inhibits unphosphorylated c-FMS kinase (uFMS) and uKIT with IC50s of <0.01 μM and 0.1-1 μM, respectively .
loading...
    loading...
Cat. No.: HY-101544
CAS No.: 1314021-57-2
Target:  

FGFR

Research Areas:  

Cancer

ARQ 069, an analog of ARQ 523, inhibits FGFR in an enantiospecific manner. ARQ 069 targets the unphosphorylated, inactive forms of FGFR1/FGFR2 kinases (IC50s of 0.84 μM and 1.23 μM, respectively). ARQ 069 inhibits FGFR1/FGFR2 autophosphorylation (IC50s of 2.8 and 1.9 μM, respectively) through a mechanism in a non-ATP competitive dependent manner .
loading...
    loading...
Cat. No.: HY-125444
CAS No.: 1622059-04-4
Target:  

LIM Kinase (LIMK)

Research Areas:  

Neurological Disease Cancer

TH251 is a LIMK1 and LIMK2 inhibitor with IC50s of 52 nM and 47 nM against LIMK1 and LIMK2, respectively. TH251 binds to inactive αC-out and DFG-out LIMK1 conformations, inhibits unphosphorylated LIMK1 and LIMK2 enzymatic activity, and exhibits unchanged potency despite PAK-mediated phosphorylation of either kinase. TH251 can be used for the research of cancers, glaucoma, and CNS diseases .
loading...
    loading...